Novartis' Strong Innovation Supports Industry-Leading Margins
Novartis is positioned for steady long-term cash flows due to strong intellectual property in key therapeutic areas like oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic health. Despite near-term challenges from patent losses on Entresto, the company's robust pipeline and newly launched drugs are …